Bovie Medical Corporation Cost of Revenue

Cost of Revenue of APYX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cost of Revenue growth rates and interactive chart. Cost of revenue refers to the direct costs attributable to the production of the goods or supply of services by an entity. It is also commonly known as the “cost of goods sold (COGS)”. Cost of sales measures the cost of goods produced or services provided in a period by an entity. It includes the cost of the direct materials used in producing the goods, direct labor costs used to produce the good, along with any other direct costs associated with the production of goods. In case of services cost of sales includes the labor cost or salaries of the employees and other directly attributable costs. Cost of sales does not include indirect expenses such as distribution costs and marketing costs. It appears on the income statement and is deducted from the sales revenue for the calculation of gross profit (or gross margin).


Highlights and Quick Summary

  • Cost of Revenue for the quarter ending June 29, 2020 was $2.2 Million (a 9.39% increase compared to previous quarter)
  • Year-over-year quarterly Cost of Revenue decreased by -13.92%
  • Annual Cost of Revenue for 2019 was $9.14 Million (a 58.18% increase from previous year)
  • Annual Cost of Revenue for 2018 was $5.78 Million (a 76.4% increase from previous year)
  • Annual Cost of Revenue for 2017 was $3.28 Million (a -11.53% decrease from previous year)
  • Twelve month Cost of Revenue ending June 29, 2020 was $9.32 Million (a 2.5% increase compared to previous quarter)
  • Twelve month trailing Cost of Revenue increased by 3.48% year-over-year
Trailing Cost of Revenue for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$9.32 Million $9.09 Million $9.14 Million $9 Million
Visit stockrow.com/APYX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cost of Revenue of Bovie Medical Corporation

Most recent Cost of Revenueof APYX including historical data for past 10 years.

Interactive Chart of Cost of Revenue of Bovie Medical Corporation

Bovie Medical Corporation Cost of Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $2.2 $2.01
2019 $2.54 $2.56 $1.98 $2.07 $9.14
2018 $2.4 $1.15 $1.15 $1.19 $5.78
2017 $0.96 $0.74 $4.76 $4.16 $3.28
2016 $4.66 $5.0 $4.6 $4.45 $3.7
2015 $4.78 $4.59 $4.13 $3.45 $16.96
2014 $5.03 $4.87 $5.07 $3.73 $18.69
2013 $3.56 $3.55 $3.81 $3.55 $14.46
2012 $4.04 $3.78 $4.58 $3.94 $16.34
2011 $3.51 $3.65 $3.8 $3.72 $14.68
2010 $3.55 $3.8 $3.58 $3.31 $14.24
2009 $3.74 $15.1

Business Profile of Bovie Medical Corporation

Sector: Medical
Industry: Med Prods
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.